Zhu, Zi-ning
You, Chong-zhao
Yuan, Qing-ning
Xu, Jiu-yin
Gu, Zong-yue
Huang, Zheng
Liu, Miao
Shan, Bei
Wang, James Jiqi
Hu, Wen
Wang, Kai
Yin, Wan-chao
Xu, You-wei
Xu, H. Eric
Wu, Can-rong
Article History
Received: 26 October 2025
Accepted: 24 November 2025
First Online: 16 January 2026
Competing interests
: ZH, ML, and BS are employed by BioFront Therapeutics. HEX is one of the Associate Editors of APS and was not involved in the peer review or the decision making of the article. The authors declare no other competing interests.